{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:23:50Z","timestamp":1760909030486},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1093\/ajcp\/aqx012","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T13:24:12Z","timestamp":1485782652000},"page":"453-460","source":"Crossref","is-referenced-by-count":6,"title":["CD4-Negative Variant of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm With a Novel PBRM1 Mutation in an 11-Year-Old Girl"],"prefix":"10.1093","volume":"147","author":[{"given":"Nuri","family":"Yigit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa Fernanda","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa Giulino","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attilio","family":"Orazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,4,15]]},"reference":[{"key":"key\n\t\t\t\t20170420131226_aqx012-B1","first-page":"145","volume-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissue","year":"2008","edition":"4th ed"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/107327481402100404","article-title":"Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy","volume":"21","year":"2014","journal-title":"Cancer Control"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B3","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","year":"2016","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/PAP.0b013e3181bb6bc2","article-title":"Plasmacytoid dendritic cells: physiologic roles and pathologic states","volume":"16","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B5","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3324\/haematol.2010.026179","article-title":"Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications","volume":"95","year":"2010","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/PAS.0000000000000156","article-title":"Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients","volume":"38","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B7","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.humpath.2005.07.002","article-title":"CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype","volume":"36","year":"2005","journal-title":"Hum Pathol"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0b013e3181c5e26b","article-title":"Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients","volume":"34","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2141.2009.07679.x","article-title":"Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia","volume":"145","year":"2009","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/annonc\/mdh268","article-title":"CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature","volume":"15","year":"2004","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B11","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1080\/10428190410001723232","article-title":"Blastic natural killer (NK)\u2013cell lymphoma: report of an unusual CD4 negative case and review of the CD4 negative neoplasms with blastic features in the literature","volume":"45","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B12","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1600-0560.2007.00915.x","article-title":"CD4-negative variant of CD4+\/CD56+ hematodermic neoplasm: description of three cases","volume":"35","year":"2008","journal-title":"J Cutan Pathol"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B13"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B14","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1101\/gr.131110.111","article-title":"Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics","volume":"22","year":"2012","journal-title":"Genome Res"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature09639","article-title":"Exome sequencing identifies frequent mutation of the SWI\/SNF complex gene PBRM1 in renal carcinoma","volume":"469","year":"2011","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B16"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B17","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/14737159.2015.1068122","article-title":"BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies","volume":"15","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-012414-040445","article-title":"SWI\/SNF chromatin remodeling and human malignancies","volume":"10","year":"2015","journal-title":"Annu Rev Pathol"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/PPO.0b013e3182a102d1","article-title":"PBRM1 and BAP1 as novel targets for renal cell carcinoma","volume":"19","year":"2013","journal-title":"Cancer J"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B20","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1158\/0008-5472.CAN-10-2167","article-title":"Aurora A is a repressed effector target of the chromatin remodeling protein INI1\/hSNF5 required for rhabdoid tumor cell survival","volume":"71","year":"2011","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/leu.2013.283","article-title":"Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm","volume":"28","year":"2014","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B22","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1182\/blood.V122.21.2581.2581","article-title":"Molecular screening in blastic plasmacytoid dendritic cell neoplasms reveals mutations in TET2 and ASXL1 in the majority of patients","volume":"122","year":"2013","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B23","first-page":"109","volume-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissue","year":"2008","edition":"4th ed"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/path.2995","article-title":"Concurrent CIC mutations, IDH mutations, and 1p\/19q loss distinguish oligodendrogliomas from other cancers","volume":"226","year":"2012","journal-title":"J Pathol"},{"key":"key\n\t\t\t\t20170420131226_aqx012-B25"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/147\/5\/453\/13699962\/aqx012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T04:46:57Z","timestamp":1601527617000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article-lookup\/doi\/10.1093\/ajcp\/aqx012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,15]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,4,15]]},"published-print":{"date-parts":[[2017,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqx012","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,15]]}}}